9 METERS BIOPHARMA, INC. Quarterly Interest Expense in USD from Q2 2015 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
9 Meters Biopharma, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2015 to Q1 2023.
  • 9 Meters Biopharma, Inc. Interest Expense for the quarter ending March 31, 2023 was $753K, a 247538% increase year-over-year.
  • 9 Meters Biopharma, Inc. Interest Expense for the twelve months ending March 31, 2023 was $3.42M, a 99661% increase year-over-year.
  • 9 Meters Biopharma, Inc. annual Interest Expense for 2022 was $2.67M, a 5552% increase from 2021.
  • 9 Meters Biopharma, Inc. annual Interest Expense for 2021 was $47.2K, a 98.8% decline from 2020.
  • 9 Meters Biopharma, Inc. annual Interest Expense for 2020 was $4.05M, a 122% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $3.42M $753K +$753K +247538% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $2.67M $1.82M +$1.82M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 $848K $847K +$845K +42912% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $2.27K $0 -$1.15K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $3.43K $304* -$43.8K -99.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $47.2K $0 -$335K -100% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 $383K $1.97K -$2.12M -99.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $2.5M $1.15K -$1.02M -99.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $3.52M $44.1K -$529K -92.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $4.05M $335K -$159K -32.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 $4.2M $2.12M +$1.65M +349% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $2.56M $1.02M +$588K +136% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.97M $573K +$146K +34.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $1.83M $494K -$64.1K -11.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 $1.89M $472K -$566K -54.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $2.46M $432K -$462K -51.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $2.92M $427K -$3.23M -88.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $6.15M $558K +$404K +261% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 $5.75M $1.04M +$928K +839% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $4.82M $894K +$795K +799% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $4.03M $3.66M +$3.59M +5011% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $436K $155K -$54.3K -26% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $491K $111K +$85.5K +342% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $405K $99.5K -$240K -70.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $645K $71.6K -$180K -71.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $825K $209K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 $25K -$50K -66.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $339K +$240K +242% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 $252K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-19
Q3 2015 $75K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-16
Q2 2015 $99K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.